Texas Yale Capital Corp’s VanEck Biotech ETF BBH Stock Holding History

Texas Yale Capital Corp’s Portfolio BBH Stock Details BBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,085	Closed	-$345K	–	496
2025 Q3	$345K	Hold	2,085	–	–	0.01%	403
2025 Q2	$320K	Hold	2,085	–	–	0.01%	392
2025 Q1	$328K	Hold	2,085	–	–	0.01%	377
2024 Q4	$327K	Buy	2,085 +360	+21%	+$60.6K	0.01%	380
2024 Q3	$306K	Hold	1,725	–	–	0.01%	389
2024 Q2	$291K	Hold	1,725	–	–	0.01%	377
2024 Q1	$287K	Hold	1,725	–	–	0.01%	385
2023 Q4	$285K	Hold	1,725	–	–	0.01%	377
2023 Q3	$269K	Hold	1,725	–	–	0.01%	370
2023 Q2	$269K	Hold	1,725	–	–	0.01%	382
2023 Q1	$280K	Hold	1,725	–	–	0.01%	385
2022 Q4	$276K	Hold	1,725	–	–	0.02%	386
2022 Q3	$243K	Hold	1,725	–	–	0.02%	388
2022 Q2	$251K	Buy	+1,725	New	+$257K	0.02%	385

Other funds holding BBH

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Raymond James Financial St Petersburg, Florida $324B AUM 22.36% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

MIM

Miller Investment Management West Conshohocken, Pennsylvania $1.01B AUM 13.96% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

BFG

Bleakley Financial Group Fairfield, New Jersey $6.39B AUM 26.33% 1-Year Est. Return

CCA

Conservest Capital Advisors Wynnewood, Pennsylvania $1.1B AUM 16.5% 1-Year Est. Return

Texas Yale Capital Corp's BBH Position: Q4 2025 in Review

Texas Yale Capital Corp sold out of VanEck Biotech ETF (BBH) in Q4 2025, closing a stake of 2,085 shares — an estimated $345K sold.

Texas Yale Capital Corp first reported a position in BBH in Q2 2022 and held it in 14 quarters. The position peaked at $345K in Q3 2025. 111 funds tracked by Wall St. Rank hold BBH as of Q4 2025.

Texas Yale Capital Corp reported no remaining VanEck Biotech ETF position as of Q4 2025 after selling out during the quarter.
Texas Yale Capital Corp sold 2,085 VanEck Biotech ETF shares in Q4 2025, an estimated $345K.
Texas Yale Capital Corp first reported a position in VanEck Biotech ETF in Q2 2022 and held it in 14 quarters.
Texas Yale Capital Corp's VanEck Biotech ETF position peaked at $345K in Q3 2025.
111 funds tracked by Wall St. Rank held VanEck Biotech ETF as of Q4 2025.

Based on Texas Yale Capital Corp's 13F filing for Q4 2025, filed 10 Feb 2026.